Transcatheter arterial embolization
(TAE) has been widely applied
in treatments of unresectable or hypervascular tumors, but the procedure
of TAE is complicated possibly brings inherent risks. Here, inspired
by pH-responsive drug delivery systems, a new method of noninvasive
and target embolization therapy by intravenous injection was developed.
This method is based on a type of acidic microenvironment-responsive
hyperbranched poly(amino acid) (HPTTG) to avoid using catheterization
and real-time image guidance angiography, simplifying the procedure,
elevating compliance and general applicability of embolization therapy.
The pH value of the sol-to-gel phase transition with decreasing pH
of HPTTG was controlled by adjusting the ratio of acidic amino acids
in copolymers. The results of the tumor-bearing animal experiment
indicate that the HPTTG have an excellent target and embolic ability;
they accumulate the most at the tumor site in 8 h postinjection. Blood
vessels of the tumors were occluded, and the tumors were inhibited
and necrotized in about 20 days. Therefore, it is expected that HPTTG
not only can be used as novel embolic materials for efficient noninvasive
embolization therapy of many solid tumors but also can be used as
a multifunctional platform for combined theranostics, for example,
combination with controlled release, thermal ablation, multimodal
imaging, synergistic therapy, etc.